This company profile is not publicly available
Prescription drugs makers
|Bristol-Myers Squibb Company||USA||website|
|Bristol-Myers Squibb Company|
In 2019, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts to manage and govern freshwater resources. Responding companies are scored on six key metrics: transparency; governance & strategy; measuring & monitoring; risk assessment; targets & goals; and value chain engagement. This company received a CDP Water Security Score of B.
[Source 2019][More on Human Rights]
This company received a score of 61.9/100 in the Newsweek Green Ranking 2017, which ranks the world's largest publicly traded companies on eight indicators covering energy, greenhouse gases, water, waste, fines and penalties, linking executive pay to sustainability targets, board-level committee oversight of environmental issues and third-party audits. Ranking methodology by Corporate Knights and HIP Investor.
[Source 2017][More on Sustainability Reporting]
As You Sow's 2016 report, 'The 100 Most Overpaid CEOs', reveals the 100 most overpaid CEOs from USA's 500 largest public companies (as determined by the S&P 500 list). This company's CEO, Lamberto Andreotti came in at number 14 on the list, having been paid US$27,062,382 in 2015. According to the report, "Most CEOs have come to be grossly overpaid, and that overpayment is harmful to the companies, the shareholders, the customers, the other employees, the economy, and society as a whole."
[Source 2016][More on Finance]
In 2007, Bristol-Myers Squibb and a subsidiary paid $515 million to settle allegations of illegal pricing and marketing of its drugs from 1994 through 2005. Among the misreported prices were those for antidepressant Serzone, plus various oncology and generic drugs.
[Source 2007][More on Governance]
This company was named in the Working Mother 100 Best Companies 2018 for being a mum-friendly employer. Listed companies help working parents succeed at home and at work by providing expanded parental leaves, more flexibility with work hours, assistance for special needs, and opportunities for career development.
[Source 2018][More on Workers Rights]
In 2019, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts to reduce greenhouse gas emissions and mitigate climate change risk. Responding companies are scored across four key areas: disclosure; awareness; management; and leadership. This company received a CDP Climate Change Score of C.
[Source 2019][More on Climate Change]
California, the UK and Australia have all enacted legislation requiring companies operating within their borders to disclose their efforts to eradicate modern slavery from their operations and supply chains. Follow the link to see this company's disclosure statement.
[Source 2017][More on Human Rights]
This company received an S&P Global ESG Score of 54/100 in the Pharmaceuticals category of the 2019 SAM Corporate Sustainability Assessment, an annual evaluation of companies' sustainability practices. The rankings are based on an analysis of corporate economic, environmental and social performance, assessing issues such as corporate governance, risk management, environmental reporting, climate strategy, human rights and labour practices.
[Source 2019][More on Sustainability Reporting]
OpenSecrets.org tracks the influence of money on U.S. politics, and how that money affects policy and citizens' lives. Follow link to see this company's record of political donations, lobbying, outside spending and more.
|Company Structure||Listed Public Company|
|Revenue||US$19.4 billion in 2004|
|# Employees||43,000 in 2004 in World|
|Subsidiaries||Bristol-Myers Squibb Australia Pty Ltd|
|Address||345 Park Ave, New York, NY, 10154, USA|